Mario Chojkier

This inventor holds 14 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: University of California, The United States Government as Represented by the Department of Veterans Affairs, Other. Active years: 1999-2019.

USPTO Granted Patents = 14

% Patents Active = 71.4

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 98(Granted Patents)

Location History:

San Diego, CA (US) (1999 - 2012)
Delmar, CA (US) (2018 - 2019)

Company Filing History:

12 out of 15,988

University of California

patents

2 out of 955

The United States Government as Represented by the Department of Veterans Affairs

patents

2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2019

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10434134 - Peptide treatment for inflammation and fibrosis (2019-10-08),

2. 10054600 - Biomarker composite test for hepatic vein pressure gradient and cirrhosis treatment (2018-08-21),

3. 8129349 - Treatment of disease by inducing cell apoptosis (2012-03-06),

4. 7655472 - Treatment of disease by inducing cell apoptosis (2010-02-02),

5. 7402567 - Treatment of disease by inducing cell apoptosis (2008-07-22),

6. 6811988 - Compositions and methods for diagnosing Alzheimer's disease (2004-11-02),

7. 6495335 - Compositions and methods for diagnosing alzheimer's disease (2002-12-17),

8. 6420428 - Treatment and prevention of hepatic disorders (2002-07-16),

9. 6369097 - Treatment and prevention of hepatic disorders (2002-04-09),

10. 6348493 - Treatment and prevention of hepatic disorders (2002-02-19),

11. 6218437 - Treatment and prevention of hepatic disorders (2001-04-17),

12. 6147123 - Treatment and prevention of hepatic disorders (2000-11-14),

13. 6075027 - Treatment and prevention of hepatic disorders (2000-06-13),

14. 5922757 - Treatment and prevention of hepatic disorders (1999-07-13),

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]

1 patent pending (EPO):

Please report any incorrect information to [email protected]